Works matching DE "REATA Pharmaceuticals Inc."
Results: 2
Deal watch: Abbott boosts investment in NRF2 activators for reducing oxidative stress.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 2, p. 96, doi. 10.1038/nrd3655
- By:
- Publication type:
- Article
RTA 744 for treatment of malignant glioma receives orphan drug status.
- Published in:
- Expert Review of Anticancer Therapy, 2006, v. 6, n. 11, p. 1536
- Publication type:
- Article